WHO investigating links among cough syrup deaths, considers advice for parents, Health News, ET HealthWorld

New Delhi: The World Health Organization (WHO) is investigating whether there is any connection between manufacturers whose contaminated cough syrups it has linked to the deaths of more than 300 children in three countries. Citing “unacceptable levels” of toxins in the products, the WHO is seeking more information about the specific raw materials used by six manufacturers in India and Indonesia to produce medicines linked to the recent deaths, as well as whether the companies obtained them from some of the same suppliers, the person said. The WHO has not…

Read More

Ready to assist in probe: WHO after Uzbekistan claims child deaths from Indian cough syrup, Health News, ET HealthWorld

New Delhi: As many as 18 children died of acute respiratory disease after having a cough syrup manufactured by an Indian pharmaceutical firm named Doc-Max, the Health Ministry of Uzbekistan has claimed. In response to an email from ANI, seeking further details on the deaths, the World Health Organisation (WHO) said, “The WHO is in contact with the health authorities in Uzbekistan and is ready to assist in further investigations.” Previously, 66 children had died in Gambia allegedly after consuming India-made cough syrups. However, the Gambian government had denied any…

Read More

Drug Factories Inspection: India inspects drug factories as Gambia controversy lingers, Health News, ET HealthWorld

New Delhi: India’s pharmaceuticals regulator has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company’s cough and cold syrups were linked to deaths in Gambia. India is known as the “pharmacy of the world” and its pharmaceuticals exports have more than doubled over the past decade to $24.5 billion in the past fiscal year. The deaths of at least 70 children in Gambia has dented the industry’s image, though India says the drugs made…

Read More

‘WHO stands by its action on Gambia cough syrup issue’ – ET HealthWorld

New Delhi: The World Health Organization (WHO) on Friday reiterated that its tests in Ghana and Switzerland had confirmed excess levels of ethylene and diethylene in India-made children’s cough syrups that were available in The Gambia, contradicting the Indian government’s claim. The UN health body said it stands by its action to issue a statement warning about the medicines made by Sonepat-based Maiden Pharmaceuticals. India had on Thursday said quality tests on the samples lifted from Maiden Pharmaceuticals – which has been in the dock for allegedly causing deaths of…

Read More

WHO drew premature link between children deaths in Gambia, India-made cough syrups: DCGI – ET HealthWorld

New Delhi: The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country’s pharmaceutical products across the globe, India’s drug regulator has told the global health body. In the latest letter to Dr Rogerio Gaspar, Director (Regulation and Prequalification) at WHO, Drugs Controller General of India (DCGI) Dr V G Somani said a statement issued by the global health body in October in the wake of the deaths “was unfortunately amplified by the global…

Read More

Gambia deaths: ‘WHO yet to give relevant papers’ – ET HealthWorld

The Indian government has not been able to make headway into the mysterious deaths of children in Gambia as the World Health Organization (WHO) has failed to provide it “relevant documents” needed to investigate and find causality between the deaths and cough syrups made by Maiden Pharmaceuticals, people in the know told the media agency. India’s drug regulator has written thrice to the WHO to provide documents but there has been no response, they said. Last month, the WHO had issued a warning on cough syrups after which Indian health…

Read More

India halts cough syrup production at factory linked to Gambia deaths – ET HealthWorld

New Delhi: Authorities have halted production of cough syrup at a factory of Maiden Pharmaceuticals, a Haryana minister said on Wednesday, after a WHO report that the medicine may be linked to the deaths of dozens of children in Gambia. Haryana health minister Anil Vij told Reuters partner ANI that authorities inspected a Maiden factory near the town of Sonipat and found 12 violations of good practices. Production was ordered stopped, Vij said. The WHO said last week that laboratory analysis of four Maiden products – Promethazine Oral Solution, Kofexmalin…

Read More